Trade Now Open an Account

Stock Market

Company Info

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Jenburkt Pharmaceuticals Ltd.

May 20, 04:01 BSE 1130.00 (+ 29.10 2.64%)

Volume1791

Prev. Close
1100.90

Open Price
1096.10

Today's Low / High

1076.50 1145.00

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

735.20 1375.00

Jenburkt Pharmaceuticals Ltd.is not traded in NSE

Standalone

(₹ in Crs.)

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	44.13	44.13	45.89	45.89	45.89

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	4.41	4.41	4.59	4.59	4.59
Total Share Capital	4.41	4.41	4.59	4.59	4.59

Reserves and Surplus	140.53	117.98	112.79	93.88	75.41
Total Reserves and Surplus	140.53	117.98	112.79	93.88	75.41
Total Shareholders Funds	144.94	122.39	117.38	98.47	80.00

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	0.79	0.72	0.86	0.08	0.00
Other Long Term Liabilities	2.99	2.94	3.43	3.90	4.26
Total Non-Current Liabilities	3.78	3.66	4.29	3.99	4.26

CURRENT LIABILITIES
Short Term Borrowings	0.00	2.44	5.82	3.71	3.44
Trade Payables	6.26	6.10	7.11	3.61	5.23
Other Current Liabilities	9.19	6.97	8.09	9.33	8.96
Short Term Provisions	0.93	0.26	0.26	1.27	2.17
Total Current Liabilities	16.38	15.76	21.28	17.93	19.80

Total Capital And Liabilities	165.10	141.81	142.95	120.38	104.07

ASSETS
NON-CURRENT ASSETS
Tangible Assets	9.97	10.26	11.09	10.07	8.90
Intangible Assets	0.39	0.19	0.31	0.48	0.84
Capital Work-In-Progress	1.24	0.96	0.21	0.38	0.12
Other Assets	0.00	0.00	0.00	0.00	1.99
Fixed Assets	11.60	11.41	11.61	10.93	11.85
Non-Current Investments	16.79	11.18	7.96	6.50	2.50
Deferred Tax Assets [Net]	0.80	0.42	0.37	0.00	-0.24
Long Term Loans And Advances	0.03	0.06	0.13	0.08	0.07
Other Non-Current Assets	26.15	37.65	46.97	22.95	0.35
Total Non-Current Assets	55.37	60.72	67.05	40.46	14.53


CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.25	1.57
Inventories	8.56	8.34	9.89	7.58	10.90
Trade Receivables	19.48	16.96	15.21	14.00	17.83
Cash And Cash Equivalents	79.19	53.81	49.02	56.51	57.69
Short Term Loans And Advances	0.09	0.12	0.19	0.11	0.22
OtherCurrentAssets	2.41	1.86	1.60	1.47	1.33
Total Current Assets	109.73	81.09	75.90	79.92	89.54

Total Assets	165.10	141.81	142.95	120.38	104.07

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	16.57	19.55	16.61	16.48	16.61

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	13.31	11.18	7.96	3.93	2.50

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.25	1.57

Particulars	Mar 24
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	44.13

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	4.41
Total Share Capital	4.41
Reserves and Surplus	140.53
Total Reserves and Surplus	140.53
Total Shareholders Funds	144.94
NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	0.79
Other Long Term Liabilities	2.99
Total Non-Current Liabilities	3.78
CURRENT LIABILITIES
Short Term Borrowings	0.00
Trade Payables	6.26
Other Current Liabilities	9.19
Short Term Provisions	0.93
Total Current Liabilities	16.38
Total Capital And Liabilities	165.10
ASSETS
NON-CURRENT ASSETS
Tangible Assets	9.97
Intangible Assets	0.39
Capital Work-In-Progress	1.24
Other Assets	0.00
Fixed Assets	11.60
Non-Current Investments	16.79
Deferred Tax Assets [Net]	0.80
Long Term Loans And Advances	0.03
Other Non-Current Assets	26.15
Total Non-Current Assets	55.37
CURRENT ASSETS
Current Investments	0.00
Inventories	8.56
Trade Receivables	19.48
Cash And Cash Equivalents	79.19
Short Term Loans And Advances	0.09
OtherCurrentAssets	2.41
Total Current Assets	109.73
Total Assets	165.10
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	16.57
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	13.31
CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00

Ready to invest with us?

Open an Account

Request for Trading/DP account closing

Investment Advisory - Number of complaints - March 2025

At the beginning of the Month	Received during the Month	Resolved during the Month	Pending at the end of the Month	Reason for the Pendency
0	0	0	0	N/A

In case, if you want to register your complaint through SEBI Score Portal, please Click here

In case, if you want to register your complaint via SMART ODR Portal, please Click here

For Cyber attack reporting Mail id : ithelpdesk@motisons.com and Contact No. :9314114189

1) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

2) For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.

3) For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.

4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

5) Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

EQUITY

Commodities

Derivatives

Company Info

Announcements

Mutual Fund

IPO

News

Currency

ETF

Insurance

Economic Indicator

Back Office

Old Back Office

Motisons Shares Private Limited

Motisons Commodities Private Limited

Open an Account

User Guide

Trading Platforms

Stock Market

BALANCE SHEET

Jenburkt Pharmaceuticals Ltd.

Ready to invest with us?